Gene · 23552
Papers1,583
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,583
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Progress of NRF2 Signaling Pathway in Promoting Proliferation of Non-small Cell Lung Cancer]. | Zhongguo Fei Ai Za Zhi | 2022 | 36167459 | PubTator, text mining | PubMed |
| Targeting EIF3C to suppress the development and progression of nasopharyngeal carcinoma. | Front Bioeng Biotechnol | 2022 | 36147539 | PubTator, text mining | PubMed |
| Control of ribosomal RNA synthesis by hematopoietic transcription factors. | Mol Cell | 2022 | 36113481 | PubTator, text mining | PubMed |
| Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges. | Molecules | 2022 | 36080304 | PubTator, text mining | PubMed |
| Mechanisms of Regulation in Intraflagellar Transport. | Cells | 2022 | 36078145 | PubTator, text mining | PubMed |
| Isc10, an inhibitor of the Smk1 MAPK, prevents activation loop autophosphorylation and substrate phosphorylation through separate mechanisms. | J Biol Chem | 2022 | 36063999 | PubTator, text mining | PubMed |
| Expression and Role of TRIM2 in Human Diseases. | Biomed Res Int | 2022 | 36051486 | PubTator, text mining | PubMed |
| The RNA-binding protein AUF1 facilitates Akt phosphorylation at the membrane. | J Biol Chem | 2022 | 36041631 | PubTator, text mining | PubMed |
| Comprehensive and Integrated Analysis Identifies ZEB1 as a Key Novel Gene in Oral Squamous Cell Carcinoma. | Contrast Media Mol Imaging | 2022 | 36034202 | PubTator, text mining | PubMed |
| New Insights into Renal Failure in a Cohort of 317 Patients with Autosomal Dominant Forms of Alport Syndrome: Report of Two Novel Heterozygous Mutations in COL4A3. | J Clin Med | 2022 | 36013122 | PubTator, text mining | PubMed |
| Mutational Landscape of CEBPA in Mexican Pediatric Acute Myeloid Leukemia Patients: Prognostic Implications. | Front Pediatr | 2022 | 35967564 | PubTator, text mining | PubMed |
| Targeting Doublecortin-Like Kinase 1 (DCLK1)-Regulated SARS-CoV-2 Pathogenesis in COVID-19. | J Virol | 2022 | 35943255 | PubTator, text mining | PubMed |
| Chemokines in progression, chemoresistance, diagnosis, and prognosis of colorectal cancer. | Front Immunol | 2022 | 35935996 | PubTator, text mining | PubMed |
| MALAT1-miRNAs network regulate thymidylate synthase and affect 5FU-based chemotherapy. | Mol Med | 2022 | 35922756 | PubTator, text mining | PubMed |
| Frontier progress of the combination of modern medicine and traditional Chinese medicine in the treatment of hepatocellular carcinoma. | Chin Med | 2022 | 35907976 | PubTator, text mining | PubMed |
| ZIP11 Regulates Nuclear Zinc Homeostasis in HeLa Cells and Is Required for Proliferation and Establishment of the Carcinogenic Phenotype. | Front Cell Dev Biol | 2022 | 35898402 | PubTator, text mining | PubMed |
| The Role of CDK Pathway Dysregulation and Its Therapeutic Potential in Soft Tissue Sarcoma. | Cancers (Basel) | 2022 | 35884441 | PubTator, text mining | PubMed |
| Peptide/protein-based macrocycles: from biological synthesis to biomedical applications. | RSC Chem Biol | 2022 | 35866174 | PubTator, text mining | PubMed |
| Aged Lens Epithelial Cells Suppress Proliferation and Epithelial-Mesenchymal Transition-Relevance for Posterior Capsule Opacification. | Cells | 2022 | 35805085 | PubTator, text mining | PubMed |
| Case Report: Extensive Tumor Profiling in Primary Neuroendocrine Breast Cancer Cases as a Role Model for Personalized Treatment in Rare and Aggressive Cancer Types. | Front Med (Lausanne) | 2022 | 35721079 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23552/papers?page=8